Press Releases InMed Pharmaceuticals to Webcast Live at VirtualInvestorConferences.com September 8th September 7, 2021 Read More » InMed Pharmaceuticals to Present at the H.C. Wainwright Ophthalmology Virtual Conference August 12, 2021 Read More » InMed Pharmaceuticals Announces Closing of US$12 Million Private Placement Priced At-the-Market under Nasdaq Rules July 2, 2021 Read More » InMed Pharmaceuticals Signs Non-binding Letter of Intent to Acquire BayMedica, a Commercial Manufacturer of Rare Cannabinoids June 29, 2021 Read More » InMed Pharmaceuticals Announces $12 Million Private Placement Priced At-the-Market under Nasdaq Rules June 29, 2021 Read More » InMed Pharmaceuticals Increases Cannabinoid Yield to 5 g/L with IntegraSyn™ in Advance of Commercial Scale Production June 17, 2021 Read More » InMed Pharmaceuticals to Present at the 2021 BIO Digital Conference June 9, 2021 Read More » InMed Pharmaceuticals Reports Third Quarter Fiscal 2021 Financial Results May 13, 2021 Read More » InMed Pharmaceuticals to Report Third Quarter Fiscal 2021 Financial Results May 6, 2021 Read More » InMed to Present at Canaccord Genuity’s 5th Annual Global Cannabis Conference on May 11th, 2021 May 4, 2021 Read More » InMed Pharmaceuticals Submits Clinical Trial Applications to Evaluate INM-755 (Cannabinol) Cream in a Phase 2 Trial for Epidermolysis Bullosa April 28, 2021 Read More » InMed Pharmaceuticals Announces Voluntary Delisting from TSX April 27, 2021 Read More » InMed Pharmaceuticals Achieves 2g/L Cannabinoid Yield with IntegraSyn™ April 26, 2021 Read More » InMed to Participate in Upcoming Investor Conferences in April and May 2022 April 19, 2021 Read More » InMed to Present at Virtual Conferences in March 2021 March 3, 2021 Read More » InMed Announces Closing of US$4.5 Million Private Placement February 16, 2021 Read More » InMed Pharmaceuticals Reports Second Quarter Fiscal 2021 Financial Results February 11, 2021 Read More » InMed Pharmaceuticals to Report Second Quarter Fiscal 2021 Financial Results February 6, 2021 Read More » InMed Announces US$4.5 Million Private Placement February 5, 2021 Read More » InMed Pharmaceuticals to Participate in 2021 Cannabinoid-Derived Pharmaceuticals Industry Review Summit Europe January 19, 2021 Read More » « Previous Page1 Page2 Page3 Page4 Page5 Page6 Page7 Page8 Page9 Page10 Page11 Page12 Page13 Page14 Page15 Page16 Next » Management Learn More Board of Directors Learn More Scientific Advisory Board Learn More Investor Alerts Sign up to receive news releases from InMed Pharmaceuticals. SIGN UP
InMed Pharmaceuticals to Webcast Live at VirtualInvestorConferences.com September 8th September 7, 2021 Read More »
InMed Pharmaceuticals to Present at the H.C. Wainwright Ophthalmology Virtual Conference August 12, 2021 Read More »
InMed Pharmaceuticals Announces Closing of US$12 Million Private Placement Priced At-the-Market under Nasdaq Rules July 2, 2021 Read More »
InMed Pharmaceuticals Signs Non-binding Letter of Intent to Acquire BayMedica, a Commercial Manufacturer of Rare Cannabinoids June 29, 2021 Read More »
InMed Pharmaceuticals Announces $12 Million Private Placement Priced At-the-Market under Nasdaq Rules June 29, 2021 Read More »
InMed Pharmaceuticals Increases Cannabinoid Yield to 5 g/L with IntegraSyn™ in Advance of Commercial Scale Production June 17, 2021 Read More »
InMed to Present at Canaccord Genuity’s 5th Annual Global Cannabis Conference on May 11th, 2021 May 4, 2021 Read More »
InMed Pharmaceuticals Submits Clinical Trial Applications to Evaluate INM-755 (Cannabinol) Cream in a Phase 2 Trial for Epidermolysis Bullosa April 28, 2021 Read More »
InMed to Participate in Upcoming Investor Conferences in April and May 2022 April 19, 2021 Read More »
InMed Pharmaceuticals Reports Second Quarter Fiscal 2021 Financial Results February 11, 2021 Read More »
InMed Pharmaceuticals to Report Second Quarter Fiscal 2021 Financial Results February 6, 2021 Read More »
InMed Pharmaceuticals to Participate in 2021 Cannabinoid-Derived Pharmaceuticals Industry Review Summit Europe January 19, 2021 Read More »
